Hardman Johnston Global Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Hardman Johnston Global Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$48.2M	Sell	108,225 -9,855	-8%	-$4.39M	2.14%	15
2025 Q1	$57.2M	Buy	118,080 +3,416	+3%	+$1.66M	2.73%	12
2024 Q4	$46.2M	Sell	114,664 -245	-0.2%	-$98.7K	1.91%	16
2024 Q3	$53.4M	Sell	114,909 -6,911	-6%	-$3.21M	2.09%	16
2024 Q2	$57.1M	Sell	121,820 -36,961	-23%	-$17.3M	2.21%	15
2024 Q1	$66.4M	Sell	158,781 -14,180	-8%	-$5.93M	2.29%	16
2023 Q4	$70.4M	Sell	172,961 -2,882	-2%	-$1.17M	2.26%	17
2023 Q3	$61.1M	Sell	175,843 -1,617	-0.9%	-$562K	2.05%	16
2023 Q2	$62.4M	Sell	177,460 -9,864	-5%	-$3.47M	2.02%	17
2023 Q1	$59M	Sell	187,324 -19,403	-9%	-$6.11M	1.93%	16
2022 Q4	$59.7M	Sell	206,727 -7,273	-3%	-$2.1M	2.34%	11
2022 Q3	$62M	Sell	214,000 -17,914	-8%	-$5.19M	2.79%	7
2022 Q2	$65.4M	Sell	231,914 -13,090	-5%	-$3.69M	2.77%	9
2022 Q1	$63.9M	Buy	245,004 +36,380	+17%	+$9.49M	2.05%	17
2021 Q4	$45.8M	Buy	208,624 +19,950	+11%	+$4.38M	1.24%	23
2021 Q3	$34.2M	Sell	188,674 -3,505	-2%	-$636K	0.92%	27
2021 Q2	$38.7M	Sell	192,179 -4,015	-2%	-$810K	0.94%	24
2021 Q1	$42.2M	Buy	196,194 +500	+0.3%	+$107K	1.2%	18
2020 Q4	$46.3M	Sell	195,694 -985	-0.5%	-$233K	1.34%	17
2020 Q3	$53.5M	Sell	196,679 -2,515	-1%	-$684K	2%	12
2020 Q2	$57.8M	Sell	199,194 -18,960	-9%	-$5.5M	2.55%	10
2020 Q1	$51.9M	Sell	218,154 -1,050	-0.5%	-$250K	3.02%	8
2019 Q4	$48M	Sell	219,204 -8,056	-4%	-$1.76M	1.94%	15
2019 Q3	$38.5M	Sell	227,260 -1,790	-0.8%	-$303K	1.76%	16
2019 Q2	$42M	Sell	229,050 -9,520	-4%	-$1.75M	1.86%	15
2019 Q1	$43.9M	Sell	238,570 -4,015	-2%	-$739K	1.93%	15
2018 Q4	$40.2M	Sell	242,585 -9,635	-4%	-$1.6M	2.08%	15
2018 Q3	$48.6M	Sell	252,220 -3,930	-2%	-$757K	2.1%	13
2018 Q2	$43.5M	Buy	256,150 +67,250	+36%	+$11.4M	1.84%	12
2018 Q1	$30.8M	Buy	+188,900	New	+$30.8M	1.31%	20